Nimodipine | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Nimodipine
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Nimodipine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 8 USDMF, 4 CEP/COS, 2 EU WC, 1 KDMF, 7 NDC API, 7 Listed Suppliers, $ API Reference Price

13 API Suppliers
8 USDMF
4 CEP/COS
2 EU WC
1 KDMF
7 NDC API
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

16 Drugs in Development

16 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

53 FDF Dossiers, 11 FDA Orange Book, 31 Europe, 1 Canada, 2 South Africa, 8 Listed Dossiers

53 FDF Dossiers
11 FDA Orange Book
31 Europe
1 Canada
2 South Africa
8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 6MG/ML

SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;ORAL - 6MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 14 SPI Pharma, 2 Seqens, 7 DKSH, 1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 1 Clariant, 10 Corel Pharma Chem, 2 Finar, 5 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 3 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 14 Roquette, 7 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives, 29 Fillers, Diluents & Binders, 20 Controlled & Modified Release, 18 Film Formers & Plasticizers, 15 Taste Masking, 14 Topical, 14 Parenteral, 13 Chewable & Orodispersible Aids, 12 Thickeners and Stabilizers, 11 Direct Compression, 9 Solubilizers, 9 Empty Capsules, 8 Disintegrants & Superdisintegrants, 6 Granulation, 5 Coloring Agents, 5 Co-Processed Excipients, 4 Vegetarian Capsules, 3 API Stability Enhancers, 2 Emulsifying Agents, 2 Rheology Modifiers, 1 Surfactant & Foaming Agents, 1 Soft Gelatin

46 Coating Systems & Additives
29 Fillers, Diluents & Binders
20 Controlled & Modified Release
18 Film Formers & Plasticizers
15 Taste Masking
14 Topical
14 Parenteral
13 Chewable & Orodispersible Aids
12 Thickeners and Stabilizers
11 Direct Compression
9 Solubilizers
9 Empty Capsules
8 Disintegrants & Superdisintegrants
6 Granulation
5 Coloring Agents
5 Co-Processed Excipients
4 Vegetarian Capsules
3 API Stability Enhancers
2 Emulsifying Agents
2 Rheology Modifiers
1 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

13 NEWS #PharmaBuzz

13 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 25 Finished Drug Prices

2 US Medicaid Prescriptions
25 Finished Drug Prices

MARKET PLACE

9 APIs, 3 FDF Dossiers

9 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 1 Health Canada Patents

6 US Patents
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 3 Others

3 EDQM
3 USP
3 Others

$ API Ref.Price (USD/KG) : 315 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6AZURITY

filter Patent Number Reset all filters

6 All

01 18517997

02 110342787

03 110576070

04 111207306

05 111413277

06 111806338

filter API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 5Y

02 1Blank

filter Expiration Date Reset all filters

6 All

01 12024-05-14

02 52038-04-16

Product Main Page

01

AZURITY

BioAsia

Not Confirmed

AZURITY

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-04-16

US Patent Number : 11413277

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203340

Patent Use Code : U-2804

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-04-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AZURITY

BioAsia

Not Confirmed

AZURITY

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-04-16

US Patent Number : 10342787

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203340

Patent Use Code : U-2804

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-04-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AZURITY

BioAsia

Not Confirmed

AZURITY

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-04-16

US Patent Number : 10576070

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203340

Patent Use Code : U-2804

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-04-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

AZURITY

BioAsia

Not Confirmed

AZURITY

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-04-16

US Patent Number : 11207306

Drug Substance Claim :

Drug Product Claim :

Application Number : 203340

Patent Use Code : U-2804

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-04-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

AZURITY

BioAsia

Not Confirmed

AZURITY

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-05-14

US Patent Number : 8517997

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203340

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

AZURITY

BioAsia

Not Confirmed

AZURITY

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-04-16

US Patent Number : 11806338

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203340

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-04-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!